Ivabradine hydrochloride

Research use only, not for human use.

Ivabradine hydrochloride, a new If inhibitor with IC 50 of 2.9 μM, which is a pure heart rate lowering agent.

Ivabradine hydrochloride, a new If inhibitor with IC 50 of 2.9 μM, which is a pure heart rate lowering agent.(In Vitro):Ivabradine hydrochloride (1, 10, 20 mg/kg; i.p.) shows anticonvulsant and neuroprotective action in mice.Ivabradine hydrochloride (5, 10, 20 mg/kg;p.o.; daily for 1 weeks) lowers heart rate in mice with enhanced sympathoadrenergic activities.

——

Ivabradine hydrochloride (1, 10, 20 mg/kg; i.p.) shows anticonvulsant and neuroprotective action in mice.Ivabradine hydrochloride (5, 10, 20 mg/kg;p.o.; daily for 1 weeks) lowers heart rate in mice with enhanced sympathoadrenergic activities. Animal Model:25-30 g, 6 weeks male Swiss mice Dosage:1, 10, 20 mg/kg Administration:I.p.; for 3 days Result:Attenuated PTZ- and PICRO-induced seizures while presented an antioxidant effect in allbrain areas studied, and reduced cleaved caspase-3 expression in the CA1 and DG region of PICRO- and PTZ-treated mice, respectively.Animal Model:3-4 months transgenic (TG) mice with cardiac-restricted overexpression of b2AR Dosage:5, 10, 20 mg/kg Administration:P.o; daily for 1 weeks Result:Reduced the maximal HR increase in response to the b-agonist isoproterenol, without modifying the response of contractile parameters at 10 mg/kg.

S 16257

Endocrinology/Hormones

Adrenergic Receptor

Adrenergic Receptor

Cardiovascular Disease

——

148849-67-6

505.05

C27H37ClN2O5

>98% (HPLC)

Ethanol: 101 mg/mL (199.98 mM); Water: 82 mg/mL (162.36 mM); DMSO: 101 mg/mL (199.98 mM)

CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)C[C@H]3CC4=CC(=C(C=C34)OC)OC.Cl

——

(-20℃)

With Ice Pack

≥ 2 years